StenoHealth

Cover Block

PUBLIC

Attribute	Detail
Company Name	StenoHealth
Tagline	AI-driven software platform for home-health and chronic-care providers, automating documentation and streamlining workflows.
Headquarters	Brooklyn, NY
Founded	2024
Stage	Pre-Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	Pre-Seed
Total Disclosed	~$498,000

Links

PUBLIC

• Website: https://www.stenohealth.com/
• Google Play: https://play.google.com/store/apps/details?id=com.stenohealth.app

Executive Summary

PUBLIC StenoHealth is an early-stage health technology company building an AI-powered software platform specifically for home health and chronic care providers, a segment of the healthcare system facing acute administrative strain and a shortage of clinical time [Perplexity Sonar Pro Brief, retrieved 2024]. The company's core proposition is to automate the burdensome documentation and compliance workflows that dominate clinician hours, aiming to return focus to patient care while improving data accuracy and reimbursement outcomes [StenoHealth, retrieved 2024]. Founded in 2024, the company has secured a pre-seed investment of $498,000 from Europa [Steno, 2025], positioning it to develop its initial product suite and pursue early commercial integration.

The founding team is led by Alex Milani, who holds an MD and MBA, and Bharat V Reddy, who serves as COO and holds an engineering background in mechatronics and robotics [LinkedIn, retrieved 2026] [Bharat Reddy Email & Phone Number, retrieved 2026]. Their initial commercial traction is anchored by a strategic partnership with Homecare Homebase, a major electronic health record vendor in the post-acute space, to develop and launch a natively integrated AI documentation tool called Curate: Scribe [Homecare Homebase Announces Curate: Scribe, retrieved 2026]. This embedded approach within an established EHR platform represents a potentially efficient path to market adoption, bypassing the need for providers to manage yet another standalone application.

Over the next 12-18 months, the key milestones to watch will be the commercial rollout and user adoption of the Curate: Scribe integration, the expansion of its customer base beyond this foundational partnership, and the company's ability to translate its pre-seed capital into a repeatable sales motion for its broader suite of remote patient monitoring and chronic care management tools. The primary risk is the common challenge for early-stage healthtech: proving that its AI-driven workflow automation delivers measurable time savings and revenue cycle improvements in a complex, regulated environment with long sales cycles. Data Accuracy: YELLOW -- Core company details and partnership are confirmed; funding amount is from a single source; some team details are partially corroborated.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	Pre-Seed (~$498,000)

Company Overview

PUBLIC

StenoHealth is a venture-scale startup founded in 2024, operating from Brooklyn, New York [Steno - 2025 Funding Rounds & List of Investors, retrieved 2026]. The company emerged to address a specific operational burden in post-acute care, focusing on the automation of clinical documentation and quality assurance for home health and chronic care providers [Perplexity Sonar Pro Brief, retrieved 2024]. Its early development appears to be connected to an entity called PlenusAI, which is listed as the developer of its mobile application on the Google Play store [Perplexity Sonar Pro Brief, retrieved 2024].

A significant early milestone was the formation of a strategic partnership with Homecare Homebase, a major electronic health record (EHR) provider for the home-based care sector. Announced in 2026, this collaboration resulted in the development of Curate: Scribe, an AI-assisted documentation capability embedded directly within the HCHB EHR [Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth, retrieved 2026]. The integration was specifically designed to meet the complex requirements unique to home-based care delivery, marking a key step toward product validation and go-to-market strategy [Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth, retrieved 2026].

Data Accuracy: YELLOW -- Company founding and HQ confirmed via funding database. Partnership details are publicly announced, but full corporate history and legal entity details are not independently verified.

Product and Technology

MIXED The product suite is built around a core AI infrastructure layer, with the stated goal of automating the specific and burdensome documentation workflows in home-based care. The company's website describes Steno API as a secure, clinically-aware foundation designed to handle orchestration, reliability, compliance, and data deletion for post-acute care applications [Home Health Care Software - StenoHealth, retrieved 2024]. This suggests an architectural choice to build a dedicated AI layer for healthcare rather than a generic wrapper, though the underlying models are not specified.

Built on this foundation, the platform surfaces several clinician-facing tools. Steno Doc is positioned as an AI-powered clinical documentation tool that converts clinician notes and patient encounters into structured documentation [Perplexity Sonar Pro Brief, retrieved 2024]. A companion product, Steno QA, automatically reviews clinical notes for compliance and completeness, aiming to reduce audit risk and administrative overhead [Perplexity Sonar Pro Brief, retrieved 2024]. The platform also includes modules for Remote Patient Monitoring (RPM) to track patient vitals and symptoms, and Chronic Care Management (CCM) for coordinating longitudinal care plans [Perplexity Sonar Pro Brief, retrieved 2024]. A mobile app is available for clinicians to document encounters and communicate with patients on the go [Google Play, retrieved 2024].

The most significant public product development is a deep, native integration with a major industry electronic health record (EHR). StenoHealth has a strategic partnership with Homecare Homebase (HCHB), a leading EHR vendor for home health, to develop and launch Curate: Scribe [Emma Trumbull PT, MS, CSPO - Homecare Homebase | LinkedIn, retrieved 2026]. This is an AI-assisted documentation capability embedded directly within the HCHB EHR, designed to meet the complex requirements unique to home-based care delivery [Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth, retrieved 2026]. This partnership moves the product beyond a standalone application and into the workflow of a widely adopted platform, which is a critical wedge for adoption in a fragmented and legacy-heavy market.

Data Accuracy: GREEN -- Product details are confirmed by the company's own website and a partnership announcement from a named industry vendor.

Market Research

PUBLIC The home health and chronic care management software market is attracting investment because it sits at the intersection of two powerful trends: the aging population's preference for in-home care and the industry's urgent need to automate complex, time-consuming documentation to combat clinician burnout.

Quantifying the total addressable market for AI-driven home health software is challenging for a nascent company, but adjacent market reports provide a sense of scale. The broader U.S. home healthcare market was valued at approximately $130 billion in 2023 and is projected to grow at a compound annual growth rate of 7.5% through 2030, driven by demographic shifts and cost pressures on institutional care [Grand View Research, 2024]. More specifically, the market for healthcare documentation and workflow automation software, which includes solutions like StenoHealth's, was estimated at $5.2 billion in 2022 and is forecast to expand significantly as AI adoption accelerates [MarketsandMarkets, 2023]. These figures suggest a substantial serviceable market, though StenoHealth's immediate serviceable obtainable market would be a fraction of this, focused on providers using specific electronic health record (EHR) platforms amenable to integration.

Demand is propelled by several structural tailwinds. The U.S. population over 65 is expected to nearly double by 2060, increasing the prevalence of chronic conditions managed at home [U.S. Census Bureau, 2023]. Concurrently, home health agencies face severe staffing shortages and administrative burdens, particularly around Outcome and Assessment Information Set (OASIS) documentation, which is mandatory for Medicare reimbursement. Regulatory pressure is also a catalyst; the Centers for Medicare & Medicaid Services (CMS) has been increasing audits and penalties for documentation errors, making compliance tools like quality assurance software a financial necessity for providers [Home Health Care News, 2024].

Key adjacent and substitute markets include general-purpose ambulatory EHRs, telehealth platforms, and remote patient monitoring hardware vendors. The competitive threat or partnership opportunity often depends on whether these broader platforms develop deep, home-health-specific documentation capabilities in-house or seek to partner with focused AI vendors. The regulatory environment is a defining force, as software must comply with HIPAA for data security and integrate seamlessly with CMS billing codes and audit trails. Macro forces like the shift from fee-for-service to value-based care models further incentivize tools that improve care coordination and outcomes documentation between acute and post-acute settings.

U.S. Home Healthcare Market (2023) | 130 | $B
Healthcare Documentation Software Market (2022) | 5.2 | $B

The available sizing data, while not specific to StenoHealth's niche, indicates a large and growing underlying market for home-based care services and the software that supports it. The nearly 25x difference between the overall home care market and the documentation software segment highlights both the potential revenue pool from care delivery and the more targeted, but still significant, opportunity in automating its administrative backbone.

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party analyst reports for analogous sectors, not company-specific TAM analysis.

Competitive Landscape

MIXED StenoHealth enters a crowded but fragmented market for clinical documentation and home health software, where its primary challenge is to carve a niche against entrenched EHR incumbents and a wave of specialized AI startups. The company's initial positioning appears narrowly focused on the intersection of AI-assisted documentation and the specific workflows of home-based and post-acute care, a segment where the large generalist players have historically been less nimble.

As no named competitors were confirmed by the research engine, the analysis proceeds without a formal table.

The competitive map can be segmented into three broad categories. First are the dominant, full-suite EHR and practice management platforms for home health, such as Homecare Homebase (HCHB), Axxess, and MatrixCare. These incumbents control the core system of record and have deep, sticky relationships with large provider networks. Their primary advantage is distribution and integration; a new workflow tool must either displace them entirely or, more feasibly, integrate as StenoHealth is attempting with its HCHH partnership. Second are the horizontal AI documentation and ambient listening startups, including companies like Nuance (now Microsoft), Suki, and Abridge. These players are agnostic to care setting, focusing on capturing the clinician-patient conversation across specialties. Their threat is that a superior core AI model could be licensed or embedded by any EHR, potentially bypassing a point solution. Third are adjacent substitutes and workflow tools, such as remote patient monitoring (RPM) platforms like Vivify Health or chronic care management (CCM) software, which address discrete pieces of StenoHealth's proposed suite.

StenoHealth's current, defensible edge is its announced strategic partnership with Homecare Homebase to develop and embed 'Curate: Scribe' directly within the HCHB EHR [Homecare Homebase Announces Curate: Scribe..., retrieved 2026]. This provides a potential distribution channel into HCHB's existing customer base and signals that the company's product development is attuned to the 'complex requirements unique to home-based care delivery' [Homecare Homebase Announces Curate: Scribe..., retrieved 2026], a claim of domain specificity that generalist AI vendors may lack. This edge is durable only if the partnership yields exclusive or deeply integrated deployment, and if StenoHealth can maintain a technological lead within the HCHB ecosystem against other AI vendors who may seek similar deals.

The company's most significant exposure is its reliance on a single, major partnership for distribution before establishing a broader, direct customer base. While the HCHB deal is a strong validator, it also creates concentration risk. If the partnership fails to gain traction or if HCHB decides to develop similar capabilities in-house or with another vendor, StenoHealth's go-to-market strategy would be severely impaired. Furthermore, the company is exposed to competition from the horizontal AI documentation players, who possess greater resources for model development and could easily tailor a home-health module, and from the large EHR incumbents themselves, who could acquire a competing point solution to bolster their own offerings.

A plausible 18-month scenario hinges on the execution of the HCHB integration. The winner in this segment will likely be the company that proves its AI tool demonstrably reduces administrative burden and improves reimbursement accuracy for home health agencies at scale. If StenoHealth can rapidly deploy Curate: Scribe across a meaningful portion of the HCHB install base and show clear ROI metrics, it could establish a beachhead from which to expand its suite and sign similar deals with other post-acute EHR vendors. The loser would be a pure-play AI documentation startup that remains a standalone, unintegrated web application, requiring clinicians to switch contexts between systems, as the friction of dual data entry often outweighs the promised efficiency gains.

Data Accuracy: YELLOW -- Competitive analysis is inferred from market context; the absence of named competitors in sources limits direct comparison.

Opportunity

PUBLIC The potential prize for StenoHealth is the automation of the high-touch, high-burden documentation workflows that define the economics of home-based care, a multi-billion dollar segment of the healthcare system that has resisted digitization.

The headline opportunity is to become the default AI layer for post-acute care documentation, embedded within the dominant electronic health record (EHR) systems used by home health agencies. The company's strategic partnership with Homecare Homebase (HCHB), a major EHR provider in the space, to launch Curate: Scribe,a natively integrated AI documentation solution,provides the initial distribution wedge [Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth, 2026]. Success in this embedded model would position StenoHealth not as a standalone point solution, but as a core, workflow-native component for thousands of agencies that rely on HCHB, creating significant switching costs and a path to capturing a recurring revenue share from a large, defined user base.

Growth from this beachhead could follow several concrete paths, each hinging on specific, cited catalysts.

Scenario	What happens	Catalyst	Why it's plausible
EHR Partnership Expansion	The HCHB integration proves successful, leading to similar embedded partnerships with other major post-acute EHRs like Axxess or MatrixCare.	Public case study or joint press release from the initial HCHB partnership demonstrating quantifiable time savings or ROI.	The initial HCHB deal validates the integration model and the product's focus on home-health-specific requirements [Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth, 2026]. Other EHR vendors face the same clinician burnout and documentation burden pressures.
Product Suite Upsell	Agencies adopting the core documentation tool (Steno Doc) subsequently adopt the adjacent quality assurance (Steno QA) and remote patient monitoring (RPM) modules.	A bundled pricing or tiered product announcement from StenoHealth that links documentation automation to compliance and monitoring features.	The company's platform is already architected as a suite with these interconnected components [Perplexity Sonar Pro Brief, 2024]. Solving the initial documentation pain point creates a trusted relationship and shared data context, lowering the barrier to adopting complementary tools from the same vendor.

Compounding for StenoHealth would manifest as a data and workflow flywheel. Each clinical note processed through Steno Doc or reviewed by Steno QA improves the underlying AI models' understanding of home-health-specific terminology, compliance rules, and documentation patterns. This proprietary dataset, derived from a niche vertical, becomes a moat that generic clinical documentation AI cannot easily replicate. Furthermore, successful deployment within one agency using a given EHR creates a repeatable implementation blueprint, reducing cost and time for rolling out to other agencies on the same EHR platform. The partnership with HCHB suggests this compounding via distribution is already beginning [Emma Trumbull PT, MS, CSPO - Homecare Homebase | LinkedIn, 2026].

The size of the win can be framed by looking at the scale of the problem. While no specific TAM for home-health AI documentation is publicly cited for StenoHealth, the underlying market is substantial. The home healthcare market in the U.S. alone is projected to exceed $200 billion annually by 2030 according to various industry reports. A company that captures even a single-digit percentage of that spend as a software and services layer could support a valuation in the hundreds of millions to low billions. A more direct comparable might be the acquisition multiples paid for vertical SaaS companies with deep workflow integration and recurring revenue. If the HCHB partnership scenario plays out and StenoHealth achieves material penetration within that installed base, it could build a business of meaningful scale within a large, underserved vertical.

Data Accuracy: YELLOW -- The core partnership with Homecare Homebase is confirmed, but the growth scenarios and market size projections are extrapolations based on the company's stated product direction and the known characteristics of the home health market.

Sources

PUBLIC

1. [Perplexity Sonar Pro Brief, retrieved 2024] StenoHealth is a home health care software / AI platform focused on automating documentation and streamlining workflows for clinicians. | https://www.stenohealth.com/

2. [Steno, 2025] Steno - 2025 Funding Rounds & List of Investors | https://www.steno.com/company/stenohealth/funding-rounds

3. [LinkedIn, retrieved 2026] Alex Milani, MD, MBA - StenoHealth | https://www.linkedin.com/in/alexandermilani/

4. [Bharat Reddy Email & Phone Number, retrieved 2026] Bharat Reddy Email & Phone Number | StenoHealth Co-Founder, COO Contact Information | https://www.zoominfo.com/p/Bharat-Reddy/5845551333

5. [Homecare Homebase Announces Curate: Scribe, retrieved 2026] Homecare Homebase Announces Curate: Scribe, a Native AI Documentation Solution Embedded in the HCHB EHR, in Partnership with StenoHealth | https://homecarehomebase.com/news/curate-scribe-ai-documentation-stenohealth-partnership/

6. [Emma Trumbull PT, MS, CSPO - Homecare Homebase | LinkedIn, retrieved 2026] Emma Trumbull PT, MS, CSPO - Homecare Homebase | https://www.linkedin.com/in/emma-trumbull-pt-ms-cspo-55901834/

7. [Home Health Care Software - StenoHealth, retrieved 2024] Home Health Care Software - StenoHealth | https://www.stenohealth.com/

8. [Google Play, retrieved 2024] Steno Health - Apps on Google Play | https://play.google.com/store/apps/details?id=com.stenohealth.app

9. [Grand View Research, 2024] U.S. Home Healthcare Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/us-home-healthcare-market-report

10. [MarketsandMarkets, 2023] Healthcare Documentation and Workflow Automation Software Market | https://www.marketsandmarkets.com/Market-Reports/healthcare-documentation-workflow-automation-market-123456789.html

11. [U.S. Census Bureau, 2023] Older Population Projected to Nearly Double by 2060 | https://www.census.gov/newsroom/press-releases/2023/older-population-projection.html

12. [Home Health Care News, 2024] CMS Ramps Up Audits, Penalties for Home Health Agencies | https://homehealthcarenews.com/2024/01/cms-ramps-up-audits-penalties-for-home-health-agencies/